Primary Human Bone Marrow Mononuclear Cells (BMMC) or Human Bone Marrow derived mononuclear cells (hBM-MNCs), are a heterogenous population composed of lymphoid cells, myeloid cells, and a variety of angiogenic progenitor and stem cells. This cell mixture has great regenerative and repair ability. The hematopoietic progenitor and stem cells, as well as mesenchymal stromal cells, can work synergistically to promote vascular repair, arteriogenesis, angiogenesis and release cytoprotective growth factors and cytokines.
Why choose Human Bone Marrow Mononuclear Cells from AcceGen?
AcceGen human bone marrow mononuclear cells are isolated from whole bone marrow via density gradient separation. During this process, erythrocytes and graulocytes are selectively eliminated, ensuring a stable cell product. Cells are cryopreserved immediately after isolation to ensure best viability. Each vial contains more than 5×10^6 cells. All cell lots are tested negative for HIV-1, HBV, HCV, mycoplasma and other pathogens.
AcceGen Bone marrow mononuclear cells can be used for downstream studies or as the cell source for isolation of cell of interest.
